TheraRadar

Pharma Intelligence, Simplified

← All Targets

dopamine transporter

1 drugs
CNS
Market Leader
CONCERTA
Johnson & Johnson
1
approved indications
1
Approved Drugs
1
Companies
1
Indications
1
Therapeutic Areas
Unlock Full Target Intelligence PRO
Competitive landscape by company (1 companies)
All 1 approved drugs
Therapeutic area breakdown
Full indication list (1 indications)
Patent cliff analysis
Clinical trials pipeline
Upgrade to Pro
Starting at $99/mo

Drugs by Company

Johnson & Johnson 1 drug

By Therapeutic Area

CNS 1 drugs